This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What You Should Know: – Sware , the leading provider of comprehensive GxP validation solutions for innovative life sciences and technology companies, today announced that it will deliver GxP computer systems validation of Salesforce Life Sciences Cloud.
These inconsistencies and inaccuracies tend to compound in medical device and medicaltechnology organizations where product portfolios are continually evolving, pricing fluctuates and quotes have to be configured to meet the specifications of each customer. Improving Accuracy with CPQ. When CPQ Alone is Not The Right Fit.
AI also has the potential to identify, and even design, up to 50 new therapeutic drugs in the next decade, representing a $ 50 billion opportunity for the global pharmaceutical industry, with a 20-40% reduction in pre-clinical costs. IvorIvor has been in a candidate search for more than 30 years.
This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
GE HealthCare is a global medicaltechnology, pharmaceutical diagnostics and digital solutions provider. Based in Pittsburgh, Highmark Health is a non-profit health care company and integrated delivery network. The company does significant work in home-based care. Department of Health and Human Services (HHS).
These microservices, with 25 newly launched offerings, are poised to expedite healthcare workflows in drug discovery, medical imaging, and genomics analysis. Cadence, a computational software leader, integrates NVIDIA BioNeMo microservices into its Orion molecular design platform, enhancing drug discovery capabilities.
Many more of these have to do with “technology” and devices (e.g., And today, data integrity and health IT risks have morphed into cybersecurity threats and the spread of mis-information outside of EHRs. Let’s dive into #1 of the top first: the risks of dismissing patient, family, and caregiver concerns.
With this in mind, it is critical that both payers and providers in VBC arrangements consider how their data flows through the entire system so that key partners, such as life sciences and pharmaceutical companies – have real-world insights (RWI) about the impact their medication is having on outcomes.
. – The platform—which includes Honeywell’s TrackWise Quality , Salesforce Life Sciences Cloud , Agentforce, and other solutions—will help pharmaceutical and medicaltechnology companies deliver critical medications and healthcare devices to patients more quickly, safely, and affordably. ”
About Model N Model N is a leader in revenue optimization and compliance solutions, empowering companies in the pharmaceutical, medicaltechnology, and high-tech sectors. Upon completion, Model N will become a privately held company and its shares will be delisted from any public stock exchange.
What You Should Know: – Salesforce announced the general availability of Life Sciences Cloud , a platform for pharmaceutical ( pharma ) and medicaltechnology ( medtech ) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI.
Her research project will examine the legal and ethical implications of AI’s integration into precision medicine (PM), focusing on the distinct challenges AI introduces compared to general healthcare. 2026) research interests include innovative medicaltechnologies and chronic disease policy. Rebekah Ninan’s (J.D.
The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid. At CES 2023, we’ll see more hearing tech innovations like the CES honoree in the wearable tech category, Oticon.
It considers patient safety integral to all these priorities. A recent commentary in the Journal of Pharmaceutical Policy and Practice reveals that branded drug samples handed out by the pharmaceutical industry actually increase drug costs for everyone and can compromise patient safety.
Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA. The acceleration of digital advancements and collaborative practices amongst the pharmaceutical industry during COVID-19 have enabled a historic rollout of vaccines. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools.
National Pharmacist Day: January 12 Over the years, pharmacists have increasingly become integrated members of the healthcare team. Often regarded as the “Father of Pharmacy,” Porter founded the American Pharmaceutical Association in 1852. The era of modern pharmacy in the US can be traced back to William Procter Jr.
PBMs: The Health Care Middlemen PBMs act as intermediaries among pharmaceutical companies, drug wholesalers, pharmacies, and health insurers. How PBM Drive Up Costs This oligopolistic dominance, combined with vertical integration, has created perverse financial incentives for PBMs. Rupa Palanki is a law student (J.D.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content